Search for: "AstraZeneca Inc." Results 281 - 300 of 340
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2009, 2:44 pm
The agency also studied trials involving two other medicines that work by blocking inflammation-causing proteins called leukotrienes, AstraZeneca Pls's Accolate (zafirlukast) and Zyflo (zileuton) sold by Cornerstone Therapeutics Inc. [read post]
28 Apr 2010, 10:51 am
See Astrazeneca Pharm. [read post]
25 May 2015, 4:15 am
, Paul Inman and Ailsa Carter, have summarised last week's decision from the Court of Appeal in AstraZeneca AB & Another v KRKA dd Novo Mesto & Another [2015] EWCA Civ 484.* F1 ends up in hot water - no similarity to F1H2OIn Case T-55/13 the General Court of the European Union deals with Formula One Licensing BV's opposition against Idea Marketing SA’s Community trade mark application for 'F1H2O'. [read post]
8 Sep 2014, 4:55 am
This one is Chanel Inc. v Chanel’s Salon and Chanel Jones, 2:14-cv-00304, and sees fashion and cosmetics company Chanel as plaintiff. [read post]
12 Mar 2024, 12:46 pm by admin
Astrazeneca Pharms., LP, 500 F. [read post]
15 Jun 2012, 12:19 pm by Schachtman
AstraZeneca LP, 2009 WL 1610575 at 8 (Del. [read post]
29 Dec 2011, 6:53 am by Bexis
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
8 Dec 2015, 2:22 pm by Ben Vernia
  AstraZeneca LP and Cephalon Inc. paid the United States $26.7 million and $4.3 million, respectively, in separate settlements for allegedly underpaying rebates owed under the Medicaid Drug Rebate Program. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
15 Nov 2011, 3:58 pm by California Stem Cell Report
., Pfizer Inc. and Teva Pharmaceuticals, which have dabbled in stem cells without making major investments. [read post]
17 Jul 2007, 2:01 pm
Also, the media giant's board should dispose of publishing unit Time Inc., says Pali analyst Richard Greenfield. [read post]
18 Dec 2023, 5:01 pm by Kurt R. Karst
The company noted that the 99% claim was from a “separate analysis,” included “[s]ince Phexxi is an on-demand birth control. [read post]
31 Oct 2011, 4:58 am by Max Kennerly, Esq.
Consider those 2,200+ Reglan cases in Philadelphia: back in July, the Supreme Court’s decision in Pliva, Inc. v. [read post]
6 Jul 2017, 9:30 pm by Sarah Madigan
AstraZeneca Plc, the appellant in the case, reportedly argued that the doctrine made it too easy for drug companies to lose patents. [read post]
5 Mar 2024, 10:55 am by Evangelina Cantu
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]